FTSE 100 movers: Fresnillo leads miners lower

6th Aug 2013 15:10

Mining stocks were dominating the fallers list on the FTSE 100 on Tuesday with precious metals group Fresnillo leading the way lower following some disappointing first-half results. Fresnillo's share price was down nearly 9.5% in afternoon trade after a 27% decline in gross profit to $518.9m in the

Read more

London midday: Markets trim losses after UK data, StanChart

6th Aug 2013 11:23

Markets had recovered some lost ground by Tuesday lunchtime following some early falls, as data showed that the UK economic recovery continues to gather momentum and results from banking group Standard Chartered were well received. The FTSE 100 opened firmly in the red this morning, dampened by wea

Read more

London open: Markets fall as Fresnillo leads miners lower

6th Aug 2013 09:10

Weakness in the mining sector saw the FTSE 100 fall into the red for the third straight day on Tuesday after some disappointing results from precious metals miner Fresnillo. Asian markets had a mixed session overnight as traders reacted an interest-rate cut in Australia. The Reserve Bank of Austral

Read more

Tuesday broker round-up UPDATE

6th Aug 2013 07:13

Alent: Credit Suisse lowers target price from 430p to 420p keeping an outperform rating. UBS ups target price from 350p to 365p and maintains a neutral rating. Anglo American: Jefferies cuts target price from 1700p to 1650p and maintains a hold recommendation. Aquarius Platinum: RBC Capital shifts

Read more

Monday broker round-up UPDATE

5th Aug 2013 07:06

Anglo American: Citi increases target price from 1400p to 1500p reiterating a neutral rating. Atkins: Jefferies raises target price from 950p to 1075p and retains a hold recommendation. Capita: Berenberg takes target price from 955p to 1060p, while downgrading from buy to hold. Cineworld Group: N

Read more

Sunday share tips: Glaxo, Shell, Ladbrokes, Pennon

4th Aug 2013 16:02

Investors should look beyond bribery allegations against GlaxoSmithKline in China to the pharma giant's wider prospects, the Mail on Sunday's Midas column said. China accounts for less than 4% of Glaxo's sales and elsewhere its business is thriving. Glaxo's current profit growth looks unexciting but

Read more

GSK breast cancer drug patent revoked in India

2nd Aug 2013 14:36

A patent for GlaxoSmithKline's (GSK) breast cancer drug Tykerg has been rescinded in India, according to Reuters on Friday. It comes after a court ruling in the country disallowing patents for incremental innovations. India's Intellectual Property Appellate Board (IPAB), however, upheld a patent g

Read more

London close: Markets shrug off German downgrade rumours to finish higher

24th Jul 2013 16:56

Unconfirmed rumours of a downgrade to Germany's sovereign debt rating rattled markets on Wednesday afternoon, but stocks recovered to register moderate gains by the close of trade. The FTSE 100 finished the session up 23 points at 6,620. Senior Market Analyst Michael Hewson from CMC Markets said:

Read more

GSK addresses China scandal in second quarter results

24th Jul 2013 13:40

GlaxoSmithKline's Chief Executive, Andrew Witty, said the bribery scandal in China will inevitably impact the drugmaker's business as he unveiled second quarter results. The company has been accused of bribing doctors and government officials in China in an effort to boost its sales. Witty said

Read more

London midday: Markets boosted by earnings, Eurozone PMIs

24th Jul 2013 11:23

Upbeat corporate earnings from a number of heavyweights and improving data in the Eurozone gave UK markets a boost on Wednesday morning, as traders shrugged off concerns about manufacturing activity in China. easyJet, ARM Holdings, Tate & Lyle, Kingfisher and Compass were all trading firmly higher

Read more

London open: Markets rise as earnings impress

24th Jul 2013 08:53

Well-received updates and results from easyJet, ARM Holdings, Tate & Lyle, Compass and Kingfisher pushed the FTSE 100 firmly into positive territory on Wednesday morning, as markets shrugged off disappointing economic data from China. HSBC's flash China manufacturing purchasing managers' index (PMI

Read more

Wednesday newspaper round-up: RBS, AstraZeneca

24th Jul 2013 06:49

Royal Bank of Scotland is expected to announce a new Chief Executive to replace outgoing boss Stephen Hester, as early as next week, The Telegraph revealed. Two more AstraZeneca sales executives have been arrested by Chinese police in relation to nation-wide investigation into the drugmaking indus

Read more

Wednesday preview : GSK to address bribery claims in results

23rd Jul 2013 13:46

GlaxoSmithKline(GSK) will hog headlines on Wednesday as it reports its second quarter results in the wake of bribery claims against the drugmaker in China. Chief Executive Andrew Witty is likely to detail what action the company will take in response to allegations it bribed doctors and government

Read more

Tuesday newspaper round-up: McDonald's, GSK, BCC

23rd Jul 2013 06:50

McDonald's sales surged during the second quarter as high demand in Briton offset negative results in Germany and France, The Times reported. GlaxoSmithKline's President of International Operations, Abbas Hussain, has admitted wrongdoing by staff as China investigates the company over claims it wa

Read more

London close: Markets finish lower, earnings in focus this week

22nd Jul 2013 16:38

The FTSE 100 finished slightly lower on Monday as upcoming corporate earnings came into focus on a quiet day for economic data worldwide. Michael Hewson, Senior Market Analyst at CMC Markets, said: "With markets trading at multi-week highs investors appear to be adopting a 'wait and see' approach a

Read more